Ebola

A research team led by scientists at Vanderbilt University Medical Center has developed an antibody mixture that in animals is highly effective in blocking infection by the Ebola virus. Read More

A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members. Read More

Vanderbilt University School of Medicine (VUSM), the Vanderbilt Institute for Global Health (VIGH) and the Vanderbilt Eye Institute (VEI) have joined forces with partners in Liberia to strengthen medical education and increase access to ophthalmology care in the aftermath of the 2014-2015 West African Ebola epidemic that killed more than 11,000 people. Read More

Imagine a “DNA photocopier” small enough to hold in your hand that could identify the bacteria or virus causing an infection even before the symptoms appear. Read More

A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. Read More

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read More

Vanderbilt University Medical Center’s Office of News and Communications has received national recognition for its efforts to educate and inform the general public during the 2014 Ebola virus disease outbreak that sparked fear across the nation and around the world. Read More

Dr. Annabelle de St. Maurice rapidly is ascending to the cutting edge of addressing the practical problems of world-impacting diseases. After earning her master’s degree in public health at Vanderbilt, in July 2015 she began work in Atlanta at the Centers for Disease Control and Prevention (CDC) as an Epidemic Intelligence Service (EIS) officer. Read More

There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years. Read More

Vanderbilt researchers could be one step closer to finding a way to fight the deadly Ebola virus – thanks to two Ebola victims from Nigeria, who faced death and survived. Vanderbilt researchers developed a unique method of isolating potent Ebola-fighting antibodies from survivors’ blood and they believe these newest… Read More

In the latest VUCast: Hear from Ebola survivors helping a Vanderbilt researcher fight the deadly virus; see the high-tech way an art exhibit is bringing VU students face to face with people across the world; and find out which country music star shot his latest video with Mr. Commodore! Watch now. Read More

Two survivors of a 2014 Ebola outbreak in Nigeria visited Vanderbilt University Medical Center last week to share their experiences and participate in a study aimed at finding ways to treat the often-fatal infection. Read More

Three Nigerian physicians who survived Ebola virus disease in July 2014 after coming in direct contact with an Ebola-infected patient will speak at Vanderbilt University Medical Center next Wednesday, Sept. 16. Read More

In early September 2014, Ian Crozier, M.D.,’97, supervised the jet evacuation of a critically ill patient from Kenema, the epicenter of the raging Ebola epidemic in Sierra Leone. An exhausted Crozier told the medical team that he hoped he didn’t have to see them again. One week later, he did. Read More

Ian Crozier, M.D., a 1997 graduate of Vanderbilt University School of Medicine, and a former Vanderbilt resident, chief resident and fellow, spent three weeks treating 60 to 80 Ebola patients a day in Kenema, the epicenter of the Ebola epidemic in Sierra Leone. Read More

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus. Read More

Dr. Ian Crozier, a graduate of the infectious diseases fellowship program at Vanderbilt, was the "mystery patient" being treated for Ebola at Emory. Crozier will speak from noon to 1 p.m. on Wednesday, April 8, in Light Hall, Room 208, as part of the Flexner Dean's Lecture Series at Vanderbilt. Read More

Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola. Read More

Rachel Idowu, M.D., MPH, spent five weeks in Africa last summer assisting the Ebola outbreak response in Monrovia, Liberia’s capital and most populous city. Read More

U.S. Sen. Lamar Alexander, BA’62, discussed the Ebola epidemic with Vanderbilt physicians during a September visit to campus. Read More